Concepedia

Alexis Perry

AP

25

Publications

1.8K

Citations

19

H-Index

2002

Active since

Affiliations

University of Exeter(Current)

University of York

University of Leeds

Institute of Structural and Molecular Biology

The University of Texas Medical Branch at Galveston

Alexis Perry is an author at University of Exeter specializing in chemistry, engineering, and organic chemistry.

ORCID

Top concepts

Publications per year

2002–2020

25

Publications

25

AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro

Bartosz Szczęsny, Katalin Módis, Kazunori Yanagi et al. · Nitric Oxide · 2014 · 282 citations · Full text

, , +7

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

Revital Nimri, Tadej Battelino, Lori M. Laffel et al. · Nature Medicine · 2020 · 234 citations

, , +12

First C−H Activation Route to Oxindoles using Copper Catalysis

Johannes E. M. N. Klein, Alexis Perry, David S. Pugh et al. · Organic Letters · 2010 · 188 citations

Oxindole synthesis by direct C–H, Ar–H coupling

Alexis Perry, Richard J. K. Taylor · Chemical Communications · 2009 · 173 citations

, , +8

The novel mitochondria-targeted hydrogen sulfide (H 2 S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro

Domokos Gerő, Roberta Torregrossa, Alexis Perry et al. · Pharmacological Research · 2016 · 171 citations · Full text

Rows per page

1–5 of 25